<DOC>
	<DOCNO>NCT02287012</DOCNO>
	<brief_summary>This study aim observe effect availability plerixafor time effort associate autologous peripheral blood stem cell collection .</brief_summary>
	<brief_title>Quantification Time Effort Required Peripheral Blood Stem Cell Collection -The European Perspective</brief_title>
	<detailed_description>This non interventional study consist two part : I. Retrospective study : A medical record review conduct cover 200 patient file undergoing peripheral blood stem cell mobilization European center . II . Prospective study : Time/Motion evaluation actual apheresis - 20 event center The actual apheresis event measure consecutive patient schedule candidate peripheral blood stem mobilization apheresis area hospital . Each apheresis consider one event . Should patient receive 1 apheresis , apheresis consider one different event .</detailed_description>
	<mesh_term>JM 3100</mesh_term>
	<criteria>Patients must satisfy follow part 1 Oncology patient diagnose NonHodgkin lymphoma candidate autologous hematopoietic stem cell transplantation ( HSCT ) A patient fails achieve target CD34+ &gt; 20 cells/Âµl , first day apheresis Age &gt; 18 year Exclusion Criteria part 1 Patients : Age &lt; 18 year ; Primary diagnosis NonHodgkin lymphoma Undergone prior autologous hematopoietic stem cell transplantation ( HSCT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>